Warning: The NCBI web site requires JavaScript to function. more...
PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes.
Git A, Spiteri I, Blenkiron C, Dunning MJ, Pole JC, Chin SF, Wang Y, Smith J, Livesey FJ, Caldas C.
Breast Cancer Res. 2008;10(3):R54. Epub 2008 Jun 27.
Related citations
Differential expression of WISP-1 and WISP-2 genes in normal and transformed human breast cell lines.
Saxena N, Banerjee S, Sengupta K, Zoubine MN, Banerjee SK.
Mol Cell Biochem. 2001 Dec;228(1-2):99-104.
[Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM, Gao G, Zhang F, Chen H, Wan YF, Li XQ.
Zhonghua Yi Xue Za Zhi. 2006 Oct 24;86(39):2749-55. Chinese.
A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females.
García N, Salamanca F, Astudillo-de la Vega H, Curiel-Quesada E, Alvarado I, Peñaloza R, Arenas D.
BMC Cancer. 2005 Aug 1;5:93.
Identification of a new microRNA expression profile as a potential cancer screening tool.
Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D, Xing J.
Clin Invest Med. 2010 Apr 1;33(2):E124.
MicroRNA expression profiling of male breast cancer.
Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A.
Breast Cancer Res. 2009;11(4):R58. Epub 2009 Aug 10.
Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.
Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Bénès V, Roché H, Dalenc F, Auboeuf D, Millevoi S, Vagner S.
Cancer Res. 2009 Nov 1;69(21):8332-40. Epub 2009 Oct 13.
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR.
PLoS One. 2009 Jul 3;4(7):e6146.
mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.
Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, Weinstein JN, Pommier Y, Reinhold WC.
Mol Cancer Ther. 2010 May;9(5):1080-91. Epub 2010 May 4.
17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J, Kulp SK, Zhang Y, Sugimoto Y, Dayton MA, Govindan MV, Brueggemeier RW, Lin YC.
Anticancer Res. 2000 Jan-Feb;20(1A):11-9.
RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro.
Wild PJ, Krieg RC, Seidl J, Stoehr R, Reher K, Hofmann C, Louhelainen J, Rosenthal A, Hartmann A, Pilarsky C, Bosserhoff AK, Knuechel R.
Mol Cancer Ther. 2005 Apr;4(4):516-28.
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C.
World J Surg. 2009 Apr;33(4):698-709. Review.
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.
Bertucci F, Orsetti B, Nègre V, Finetti P, Rougé C, Ahomadegbe JC, Bibeau F, Mathieu MC, Treilleux I, Jacquemier J, Ursule L, Martinec A, Wang Q, Bénard J, Puisieux A, Birnbaum D, Theillet C.
Oncogene. 2008 Sep 11;27(40):5359-72. Epub 2008 May 19.
Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.
Wallden B, Emond M, Swift ME, Disis ML, Swisshelm K.
BMC Cancer. 2005 Oct 28;5:140.
MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL, Li L, Subramanian S.
Cancer Res. 2010 Dec 1;70(23):9570-80. Epub 2010 Nov 30.
Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.
Cancer Res. 2010 May 15;70(10):4163-73. Epub 2010 May 4.
AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
Zinda MJ, Johnson MA, Paul JD, Horn C, Konicek BW, Lu ZH, Sandusky G, Thomas JE, Neubauer BL, Lai MT, Graff JR.
Clin Cancer Res. 2001 Aug;7(8):2475-9.
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T.
Cancer Sci. 2008 Feb;99(2):280-6. Epub 2008 Jan 14.
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.
Breast Cancer Res. 2007;9(6):R76.
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.
Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavaré S, Caldas C, Miska EA.
Genome Biol. 2007;8(10):R214.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on